DMEPOS enrollment decision
Published November 4, 2026 · Coverage October 25–31, 2026, Pacific · Medium priority
In an October 27, 2026 decision, an HHS administrative law judge affirmed the earlier revocation of Monasak’s DMEPOS enrollment after its insurance and accreditation lapsed. The decision found no evidence that the supplier had submitted a written voluntary termination before it became noncompliant. The earlier notice included a one-year reenrollment bar; the decision does not establish its current status.
Suggested owner and action: DME suppliers can review insurance and accreditation expiration tracking, enrollment status and written termination procedures against their applicable requirements and exceptions.
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Enforcement Briefing report →